logo

For the Inventor, By the Inventor

Kawasaki, Japan

Yukio Iino

This inventor holds 9 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1995-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukio Iino. Retrieved from https://idiyas.com/inventor/yukio-iino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 11.1

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal9 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1995-2010

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7807663 - Therapeutic agents for diabetes (2010-10-05),
2. 7632830 - Lactam compounds and pharmaceutical use thereof (2009-12-15),
3. 7459585 - Benzene derivatives and pharmaceutical use thereof (2008-12-02),
4. 7326701 - Lactam compounds and pharmaceutical use thereof (2008-02-05),
5. 7153850 - Lactam compounds and pharmaceutical use thereof (2006-12-26),
6. 6794378 - Heterocyclic compounds and medical use thereof (2004-09-21),
7. 6703379 - Benzene derivatives and pharmaceutical use thereof (2004-03-09),
8. 6563002 - Biscyclopropanecarboxamide compounds and pharmaceutical use thereof (2003-05-13),
9. 5463078 - Anisomycin derivatives and anticancer agents, antifungal agents and (1995-10-31),

Title: Innovations of Yukio Iino in Diabetes Treatment

Introduction

Yukio Iino is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. With a total of nine patents to his name, Iino's work focuses on developing therapeutic agents that address various complications associated with diabetes.

Latest Patents

Among his latest patents, Iino has developed a pharmaceutical composition aimed at preventing and treating diabetes and its complications. This composition includes a combination of compounds, analogues, or pharmaceutically acceptable salts with a hypoglycemic agent. Another notable patent involves lactam compounds, which serve as agents for increasing sugar-transporting capacity and preventing or treating various diabetic conditions, including diabetic peripheral neuropathy and diabetic nephropathy.

Career Highlights

Iino is currently associated with Ajinomoto Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that improve the quality of life for individuals suffering from diabetes.

Collaborations

Iino collaborates with esteemed colleagues such as Takashi Yamamoto and Toshihiro Hatanaka. Their combined expertise contributes to the development of effective therapeutic solutions in the field of diabetes treatment.

Conclusion

Yukio Iino's innovative work in diabetes treatment showcases his dedication to improving healthcare through pharmaceutical advancements. His contributions are vital in the ongoing battle against diabetes and its associated complications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…